By stopping the spread of cancer cells into normal brain tissue in animal models, researchers have developed a new strategy for treating brain cancer that could improve clinical outcomes. The researchers treated animals possessing an invasive tumor with a novel molecule called imipramine blue, followed by conventional doxorubicin chemotherapy. The tumors ceased their invasion of healthy tissue and the animals survived longer than animals treated with chemotherapy alone.
Novel compound halts tumor spread, improves brain cancer treatment in animal studies
28.03.2012 19:27 
11292055 views 
0 comments
